ADDITIONAL INFO

Dihexa (PNB-0408) — Neurogenic & Neuroprotective Research Peptide

Dihexa (PNB-0408) is an experimental, orally active oligopeptide derived from angiotensin IV, designed to cross the blood-brain barrier. It is used in laboratory research to study neurogenesis, neuroprotection, and cognitive function. Preclinical studies have investigated its potential to enhance learning and memory pathways, as well as its relevance in research models of neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease.

For in-vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.

Product Details

• Compound Name: Dihexa (PNB-0408)

• Net Contents: Oral 5 mg capsules

• Primary Targets: Neurogenesis, neuroprotective pathways, cognitive function

• Research Applications: Learning and memory studies, neurodegeneration models, neural recovery, neurotrophic signaling

• Purity: ≥98% (lot-specific HPLC; Certificate of Analysis available)

• Manufactured in: GMP-compliant facility

• Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed vials at −20 °C, protected from light and moisture

• Allow vials to reach room temperature before opening

• Reconstitute under sterile laboratory conditions

• Aliquot to avoid repeated freeze–thaw cycles

• Consult SDS for hazards and first-aid guidance

Research Applications

Dihexa is commonly used in laboratory and preclinical studies to investigate:

• Neurogenesis and neural network formation

• Neuroprotective and cognitive-enhancing mechanisms

• Learning and memory pathways

• Preclinical models of Alzheimer’s and Parkinson’s disease

• Neurotrophic and synaptic signaling